Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Guidelines for Cognitive Screening, Management of MS

Mult Scler; ePub 2018 Oct 10; Kalb, Beier, et al

The National Multiple Sclerosis Society recently convened experts in cognitive dysfunction (clinicians, researchers, and lay people with MS) to review the published literature, reach consensus on optimal strategies for screening, monitoring, and treating cognitive changes, and propose strategies to address barriers to optimal care. Based on current evidence, the Society makes the following recommendations, endorsed by the Consortium of Multiple Sclerosis Centers and the International Multiple Sclerosis Cognition Society:

  • Increased professional and patient awareness/education about the prevalence, impact, and appropriate management of cognitive symptoms.
  • For adults and children (≥8 years) with clinical or magnetic resonance imaging (MRI) evidence of neurologic damage consistent with MS:
  1. As a minimum, early baseline screening with the Symbol Digit Modalities Test (SDMT) or similarly validated test, when the patient is clinically stable;
  2. Annual re-assessment with the same instrument, or more often as needed to (a) detect acute disease activity; (b) assess for treatment effects (eg, starting/changing a disease-modifying therapy) or for relapse recovery; (c) evaluate progression of cognitive impairment; and/or (d) screen for new-onset cognitive problems.
  • For adults (≥18 years): More comprehensive assessment for anyone who tests positive on initial cognitive screening or demonstrates significant cognitive decline, especially if there are concerns about comorbidities or the individual is applying for disability due to cognitive impairment.
  • For children (<18 years): Neuropsychological evaluation for any unexplained change in school functioning (academic or behavioral).
  • Remedial interventions/accommodations for adults and children to improve functioning at home, work, or school.

Kalb R, Beier M, Benedict RHB, et al. Recommendations for cognitive screening and management in multiple sclerosis care. [Published online ahead of print October 10, 2018]. Mult Scler. doi:10.1177%2F1352458518803785.

This Week's Must Reads

Stroke endovascular therapy: The more you do, the better you do, Sheth SA et al. ISC 2019, Abstract 002

Examining Brain Markers for Late-Onset Epilepsy, Neurology; ePub 2019 Jan 25; Johnson, et al

Hearing Loss Linked Cognitive Decline Risk in Men, Alzheimers Dement; ePub 2019 Jan 29; Curhan, et al

Brain Cholesterol Metabolism and PD Examined, Mov Disord; ePub 2019 Jan 25; Huang, et al

Sleep Behavior Disorder, Clinical Progression in PD, Parkinsonism Relat Disord; ePub 2019 Jan 29; Duarte Folle, et al

Must Reads in Clinical Guidelines

Guidelines for Cognitive Screening, Management of MS, Mult Scler; ePub 2018 Oct 10; Kalb, Beier, et al

DBS Guidelines for Treatment of Patients with PD, Neurosurgery; ePub 2018 Mar 12; Rughani, et al

Guidelines for Reducing Brain Injury Post-Resuscitation, Neurology; ePub 2017 May 10; Geocardin, et al

fMRI as Presurgical Tool for Patients with Epilepsy, Neurology; ePub 2017 Jan 11; Szaflarski, Gloss, et al

Guideline for Epilepsy Surgery Specimens, Committee issues SOPs for inspection, distribution, and processing